Search PubMed⌕ Search

Biomedical subjects

C Buchholz

Publications and source records attributed to C Buchholz.

32 records · Page 2Linked to original sources
PubMed1975

[Estrogenic action of cardiac glycosides. Clinical and animal experiment studies].

Vaginal smears of young girls before puberty and of postmenopausal women who were treated with digoxine, were examined on their degree of proliferation. There was no sign of any estrogenic stimulation. In female juvenile and ovarectomized fertile rats digitoxin caused no ripening of the vaginal epithelium neither in low nor in high doses. It is supposed that some steroid-hormone-like effects which are seen by glycoside-therapy, are related to stimulation of the suprarenal gland.

Age Factors↗
PubMedDate not supplied

Effect of peripheral i.v. infusion on neonatal axillary temperature measurement.

UNLABELLED: To determine whether axillary temperature in an arm with a peripheral IV infusion (PIVI) is significantly different than in the arm without a PIVI in neonates. METHOD: Twenty-nine neonates ranging in Dubowitz gestational age from 27-42 weeks were selected from Level II and III nurseries. Each had a PIVI in place in an upper extremity. Right axillary, left axillary, and rectal temperatures were taken simultaneously. RESULTS: There was no significant difference between left and right axillary temperatures using a t-test. CONCLUSION: Either axilla may be used for temperature measurement regardless of PIVI placement.

Axilla↗
PubMedDate not supplied

Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.

BACKGROUND: Donor availability remains a limiting factor for heart transplantation while transplant waiting time entails significant morbidity and mortality. This study was designed to assess the efficacy and safety of long-term beta blockade as optimization of therapy in patients with severe congestive heart failure already receiving digoxin, diuretics, and converting enzyme inhibitors awaiting transplantation. METHODS: The beta-1 antagonist metoprolol was given to 19 patients with moderate to severe congestive heart failure. Hemodynamic, clinical, and neurohormonal measurements were obtained before drug therapy and after 3 months of treatment. Patients initially received 6.25 mg of metoprolol orally twice daily which was increased to a target dose of 50 mg twice daily over several weeks. RESULTS: Metoprolol produced significant clinical, exercise, and hemodynamic benefits. Long-term therapy was associated with improvements in New York Heart Association class, ejection fraction, 6-minute walk, and peak maximal oxygen consumption. There were significant decreases in heart rate, pulmonary arterial systolic pressure, and left ventricular filling pressure with significant increases in stroke volume index and stroke work index. Four patients were removed from the transplant list after improving to New York Heart Association I. Only one patient required hospitalization during the first 6 months of therapy. There were no deaths caused by progressive heart failure; however, one patient died suddenly. CONCLUSIONS: Beta blockade with metoprolol can be safely administered to patients awaiting heart transplantation producing clinical, exercise, and hemodynamic improvements. Thus, beta blockade may prove to be a safe and cost-effective bridge to transplantation.

Adrenergic beta-Antagonists↗